Human heart-type fatty acid-binding protein as an early diagnostic marker of doxorubicin cardiac toxicity
Progressive cardiotoxicity following treatment with doxorubicin-based chemotherapy in patients with non-Hodgkin's lymphoma (NHL) may lead to late onset cardiomyopathy. So, early prediction of toxicity can lead to prevention of heart failure in these patients. The aim of this work was to investi...
Main Authors: | , , , |
---|---|
Format: | Online |
Language: | English |
Published: |
PAGEPress Publications
2009
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3222245/ |